General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0LSXKR
ADC Name
JS107
Synonyms
JS-107; JS 107
   Click to Show/Hide
Organization
Shanghai Junshi Biosciences Co., Ltd.
Drug Status
Phase 1
Indication
In total 1 Indication(s)
Pancreatic cancer [ICD11:2C10]
Phase 1
Antibody Name
Undisclosed
Antigen Name
Claudin-18.2 (CLDN18.2)
 Antigen Info 
Payload Name
Undisclosed
Linker Name
Undisclosed

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.